ProPhase Labs Uplists from Pink Sheets to OTC Market

Stock Information for Impact BioMedical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Impact BioMedical Inc.

ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart(TM) and Advances Crown Medical Collections Initiative
Join ProPhase Labs' Exclusive Live Investor Webinar and Q&A Session on February 3rd
ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture
ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value
ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories
Join ProPhase Labs' Exclusive Live Investor Webinar and Q&A Session on December 1
ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET.
ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.